Sort by
Keyphrases
Adiponectin
10%
Adiposity
13%
Anthelmintic Treatment
17%
Body Mass Index
16%
Bogor
12%
Clinical Practice Guidelines
11%
Cluster Randomized Trial
15%
COVID-19
11%
COVID-19 Patients
12%
COVID-19 Severity
10%
Diabetes
16%
Diabetes Management
13%
Diabetes Melitus
14%
Fasting Plasma Glucose
10%
Graves' Disease
12%
Helminth Infection
14%
Helminths
16%
Hemoglobin A1c (HbA1c)
12%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
20%
Hypertension
11%
Hypoglycemia
12%
Indonesia
95%
Indonesian
65%
Insulin Resistance
41%
Jakarta
26%
Leptin
9%
Lipid Accumulation Product
9%
Lipid Accumulation Product Index
9%
Meta-analysis
24%
Metabolic Profiling
12%
Metabolic Syndrome
20%
Middle-aged
12%
National Health Survey
12%
Obesity
36%
Pada
19%
Peripheral Arterial Disease
12%
Poor Prognosis
9%
Pre-diabetes (pre-DM)
12%
Ramadan Fasting
15%
Randomized Placebo-controlled Trial
11%
Risk Factors
22%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
12%
Soil-transmitted Helminths
11%
Systematic Meta-analysis
19%
TipE
14%
Type 1 Diabetes Mellitus (T1DM)
27%
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetes Mellitus Patients
37%
Type 2 Diabetic Patients
31%
Waist Circumference
26%
Medicine and Dentistry
Adiponectin
13%
Anthropometry
8%
Blood Glucose
14%
Body Mass Index
34%
C-Peptide
7%
Cardiovascular Disease
10%
Cardiovascular System
9%
Cohort Analysis
13%
COVID-19
28%
Cross Sectional Study
13%
Diabetes
65%
Diabetes Mellitus
25%
Diabetic Foot Ulcer
7%
Diabetic Ketoacidosis
7%
Diseases
9%
Endocrine Ophthalmopathy
7%
Glycemic Control
12%
Graves' Disease
9%
Health Care Cost
9%
Health Survey
13%
Helminth
14%
Helminthiasis
10%
Hemoglobin A1c
12%
High Fat Food
7%
Homeostatic Model Assessment
15%
Hypoglycemia
9%
Impaired Glucose Tolerance
13%
Insulin Resistance
30%
Latent Autoimmune Diabetes in Adults
7%
Leptin
11%
Lipid Storage
13%
Maturity Onset Diabetes of the Young
93%
Meta-Analysis
21%
Metabolic Syndrome
15%
Middle Age
7%
Non Communicable Disease
13%
Oral Antidiabetic Agent
7%
Patient Referral
12%
Patient with Type 2 Diabetes
10%
Periodontitis
7%
Placebo
9%
Prevalence
24%
Primary Health Care
8%
Quality of Life
12%
Ramadan Fasting
15%
Randomized Controlled Trial
14%
Sodium Glucose Cotransporter 2 Inhibitor
8%
Systematic Review
31%
Triacylglycerol
11%
Type 2 Diabetes
13%